FIELD: chemistry.
SUBSTANCE: use of sodium salt 11H-indeno[1,2-b]quinoxaline-11-one-oxime as a means of increasing cerebral blood flow.
EFFECT: expansion of the arsenal of agents that increase cerebral blood flow.
1 cl, 1 tab, 3 ex
Title | Year | Author | Number |
---|---|---|---|
AGENT POSSESSING ANTIAGGREGANT ACTIVITY | 2019 |
|
RU2696583C1 |
ANTIHYPERTENSIVE AGENT | 2020 |
|
RU2740379C1 |
AGENT POSSESSING HYPOLIPIDEMIC ACTIVITY | 2020 |
|
RU2732503C1 |
NEUROPROTECTIVE MEANS, HAVING THE PROPERTIES OF ANTIOXIDANT AND NITRIC OXIDE DONATOR | 2016 |
|
RU2680526C1 |
HEMOSTIMULATING AGENT | 2017 |
|
RU2647833C1 |
AGENT WITH NEUROPROTECTIVE ACTIVITY | 2019 |
|
RU2800955C2 |
METHOD FOR STIMULATION OF GRANULOCYTE COLONY-STIMULATING FACTOR PRODUCTION BY BONE MARROW CELLS IN VITRO | 2020 |
|
RU2741784C1 |
VENLAFAXINE METABOLISM INDUCER | 2021 |
|
RU2777409C1 |
MEANS FOR CEREBRAL BLOOD FLOW INCREASE | 2016 |
|
RU2655810C2 |
METHOD FOR STIMULATING PRODUCTION OF GRANULOCYTE COLONY-STIMULATING FACTOR BY BONE MARROW CELLS IN VITRO | 2021 |
|
RU2770784C1 |
Authors
Dates
2023-03-13—Published
2019-04-30—Filed